NHLBI IN THE PRESS

Drug targeting inflammation could lower risk of heart disease

Pediatric patient in hospital bed meetign with family and medical professionals.

Anti-inflammatory drugs could cut the risk of heart attacks and strokes, according to a study published on The New England Journal of Medicine. The researchers reported a 15-percent reduction in risk of a cardiovascular event, including fatal and non-fatal heart attacks and strokes, for clinical trial participants who received 150 or 300 mg of an anti-inflammatory drug, compared with those on the placebo.

Media Coverage

|
The New York Times
  • Drug targeting inflammation could lower risk of heart disease
    • |
    Washington Post
  • Major drug study opens up vast new opportunities in combating heart disease
    • |
    BBC News
  • Anti-inflammatory drug 'cuts heart attack risk'
    • |
    MedPage Today
  • ESC: At Long Last, Inflammatory Hypothesis Confirmed in CVD by CANTOS
    • |
    Forbes
  • Inflammation: Is It the New Cholesterol?
    • |
    ScienceDaily
  • Inflammatory Hypothesis Confirmed: Reducing Inflammation Without Lowering Cholesterol Cuts Risk of Cardiovascular Events